Nirsevimab (Beyfortus) – A preventative medication for RSV
By: Dr. Joseph Mechak Over the past few weeks we gained a new tool to help prevent hospitalizations and deaths related to the Respiratory Syncytial Virus (RSV). Nirsevimab (Beyfortus) is a monoclonal antibody targeted against RSV that received both FDA approval and a CDC recommendation over the past few weeks. We are SO excited
Read more
Most Commented